Kenneth A. Lock - Net Worth and Insider Trading
Kenneth A. Lock Net Worth
The estimated net worth of Kenneth A. Lock is at least $650,147 dollars as of 2024-11-13. Kenneth A. Lock is the Chief Commercial Officer of Arcutis Biotherapeutics Inc and owns about 63,429 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $650,147. Details can be seen in Kenneth A. Lock's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth A. Lock has not made any transactions after 2023-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth A. Lock
Kenneth A. Lock Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth A. Lock owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .
Click here to see the complete history of Kenneth A. Lock’s form 4 insider trades.
Insider Ownership Summary of Kenneth A. Lock
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2023-03-06 | Chief Commercial Officer |
Kenneth A. Lock Latest Holdings Summary
Kenneth A. Lock currently owns a total of 1 stock. Kenneth A. Lock owns 63,429 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 6, 2023, with a value of $650,147.
Latest Holdings of Kenneth A. Lock
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics Inc | 2023-03-06 | 63,429 | 10.25 | 650,147 |
Holding Weightings of Kenneth A. Lock
Kenneth A. Lock Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth A. Lock has made a total of 4 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 831 shares on March 6, 2023, which brought Kenneth A. Lock around $12,681.
Insider Trading History of Kenneth A. Lock
- 1
Kenneth A. Lock Trading Performance
Kenneth A. Lock Ownership Network
Ownership Network List of Kenneth A. Lock
Ownership Network Relation of Kenneth A. Lock
Kenneth A. Lock Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
Kenneth A. Lock is the Chief Commercial Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , See Remarks Patrick Burnett , and SVP and General Counsel Masaru Matsuda .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, Kenneth A. Lock made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 119,269 shares made by Patrick Burnett , a net sale of 24,466 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .
In summary, during the past 3 months, insiders sold 81,406 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,406 shares. During the past 18 months, 294,384 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 191,869 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
Kenneth A. Lock Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth A. Lock. You might contact Kenneth A. Lock via mailing address: C/o Arcutis Biotherapeutics, Inc., 2945 Townsgate Road, Suite 110, Westlake Village Ca 91361.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
